Renalytix PLC (RNLX): מכפיל EV/EBITDA

The digital renal diagnostics market is currently expanding rapidly due to high demand for early risk detection. The price indicator on the chart for Renalytix Plc (RNLX), which stands at , complements the business data. Renalytix Plc is developing a network of AI tools for nephrologists that enable the prediction of organ failure. A cloud-based biomarker analysis service ensures seamless system scaling with minimal costs per new patient.

This indicator compares the total enterprise value, including net debt, to its earnings before interest, taxes, depreciation, and amortization. The EV/EBITDA ratio trend for Renalytix Plc (RNLX) on this chart allows investors to determine the degree of asset overvaluation relative to their ability to generate cash flow. For Renalytix Plc (RNLX), this calculation is critical when assessing the impact of expanded Medicare coverage on the capitalization of AI diagnostics.